Melanin-concentrating hormone (MCH) is primarily expressed in the hypothalamus and plays a significant role in feeding behavior and energy balance. Although there are reports in the literature describing the presence of MCH in the gastrointestinal tract as well as on immune cells, peripheral roles for MCH have not yet been established. We discovered that MCH and its receptor MCHR1 were several fold upregulated in the intestinal mucosa of patients with Inflammatory Bowel Disease (IBD), and most importantly, that expression of MCHR1 was significantly higher in patients with more advanced disease. Laser capture microdissection followed by real time RT-PCR analysis demonstrated that colonocytes from IBD biopsies had increased expression of MCHR1 mRNA, compared to colonocytes obtained from controls. These findings made us hypothesize a proinflammatory role of MCH in the pathophysiology of IBD. This hypothesis is supported by our preliminary data describing that TNBS-induced experimental colitis is significantly attenuated in the MCH deficient mice. In the same model of intestinal inflammation, MCH immunoneutralization resulted in similar protective effects. Moreover, we found that activation of MCH receptors in colonocytes triggers proinflammatory signaling pathways and cytokine production. In the current proposal, we will pursue three specific aims:
In aim 1, we will investigate the effects of MCH genetic deficiency and MCHR1 peripheral antagonism in three different models of acute and chronic experimental colitis.
In aim 2, we will examine the role of MCH in intestinal neuroimmune and epithelial-immune cell interactions.
In aim 3 we will delineate the downstream effectors of MCH signaling in human colonic epithelial cells. Our proposal will be the first to decipher the mechanistic links between MCH and intestinal inflammation and may provide the foundation for the development of novel, MCH-based treatments for IBD and perhaps for additional inflammatory conditions of the gastrointestinal system and beyond.

Public Health Relevance

Melanin-Concentrating Hormone (MCH) is a neuropeptide that is produced in the brain and physiologically regulates food intake and body weight, thus it serves as an important target to treat obesity. Our preliminary studies have revealed a previously unrecognized role for MCH in intestinal inflammation, including Inflammatory Bowel Disease (IBD), which currently affects one million of Americans. Experiments outlined in this proposal will uncover the mechanisms by which MCH mediates intestinal inflammation and test an MCH antagonist as a novel approach to treat IBD and perhaps additional inflammatory conditions.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Clinical and Integrative Gastrointestinal Pathobiology Study Section (CIGP)
Program Officer
Hamilton, Frank A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Ziogas, Dimitrios C; Karagiannis, Apostolos K A; Geiger, Brenda M et al. (2014) Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10. Peptides 55:58-64
Ziogas, Dimitrios C; Gras-Miralles, Beatriz; Mustafa, Sarah et al. (2013) Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis. Am J Physiol Gastrointest Liver Physiol 304:G876-84
Chandrasekharan, Bindu; Jeppsson, Sabrina; Pienkowski, Stefan et al. (2013) Tumor necrosis factor-neuropeptide Y cross talk regulates inflammation, epithelial barrier functions, and colonic motility. Inflamm Bowel Dis 19:2535-46
Karagiannis, Apostolos K A; Ziogas, Dimitrios C; Gras-Miralles, Beatriz et al. (2013) Increased susceptibility of melanin-concentrating hormone-deficient mice to infection with Salmonella enterica serovar Typhimurium. Infect Immun 81:166-72
Townsend, Kristy L; Suzuki, Ryo; Huang, Tian Lian et al. (2012) Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway. FASEB J 26:2187-96
Wang, Yan; Ziogas, Dimitrios C; Biddinger, Sudha et al. (2010) You deserve what you eat: lessons learned from the study of the melanin-concentrating hormone (MCH)-deficient mice. Gut 59:1625-34
Flier, Sarah N; Tanjore, Harikrishna; Kokkotou, Efi G et al. (2010) Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 285:20202-12
Kokkotou, E; Espinoza, D O; Torres, D et al. (2009) Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice. Gut 58:34-40
Kokkotou, Efi; Moss, Alan C; Torres, Daniel et al. (2008) Melanin-concentrating hormone as a mediator of intestinal inflammation. Proc Natl Acad Sci U S A 105:10613-8